Oncimmune announces the success of a large-scale lung cancer study



[ad_1]

Oncimmune Holdings PLC Executive Director (LON: ONC), Dr. Adam Hill, speaks to Proactive London, which has announced positive results from a large-scale lung cancer study.

The Company's EarlyCDT-Lung test was used alongside X-rays and CT to look for the disease.

A total of 12,210 people in Scotland were followed up for two years as part of the early cancer detection test, as part of the largest randomized controlled evaluation of this type.

[ad_2]
Source link